Skip to main content
BDRX logo

BDRX

Compare

Biodexa Pharmaceuticals Plc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Values in USD · ADR · Reports in GBP

Historical stock prices for MLP & Strategic Equity Fund Inc. (MTP). MLP & Strategic Equity Fund Inc. (the Fund) is a closed-end management investment company. The Fund's investment objective is to provide a high level of after-tax total return. The Fund pursues its investment objective by investing substantially all of its net assets in publicly traded master limited partnerships (MLPs) operating in the energy infrastructure sector of the market. The Fund may purchase both domestic and international MLPs. The Fund's investment in MLPs may include ownership of MLP common units and MLP subordinated units. The Company invests in industries include oil and gas storage, oil gas explore, coal-consumfuel, gas utilities and oil gas refine. The Fund also may purchase MLP I-Shares (together with the MLPs, the MLP Entities). Nuveen Fund Advisors, Inc. is the Fund's advisor. On August 27, 2012, the Company merged with Nuveen Energy MLP Total Return Fund.

Current Price

Profile
Valuation (TTM)
Market Cap
P/E
EV
P/B
Shares Out
P/Sales
Revenue
EV/EBITDA

Biodexa Pharmaceuticals Plc (BDRX) Insider Trades

BDRX Insider Trading Activity

Track insider trading transactions for Biodexa Pharmaceuticals Plc (BDRX). Monitor recent buys, sells, and option exercises by officers, directors, and 10% beneficial owners. Insider trading activity can signal management confidence or concern about a stock's future prospects.

This page displays the most recent insider transactions for BDRX, including the insider's name, title, transaction type (purchase, sale, or option exercise), number of shares, and total value. Filter transactions by type to focus on open-market purchases or sales.

Insider buying is often viewed as a bullish signal, as insiders are putting their own capital at risk. Conversely, large insider sales may warrant further investigation. Use GoodMoat's insider trading data alongside financial analysis, quality scores, and valuation tools for a comprehensive view of Biodexa Pharmaceuticals Plc's investment outlook.